Disease | sickle cell anemia |
Phenotype | C1260402|splenic sequestration |
Sentences | 2 |
PubMedID- 26344060 | There is a need for a well-designed, adequately-powered, randomized controlled trial to assess the benefits and risks of splenectomy compared to transfusion programmes, as a means of improving survival and decreasing mortality from acute splenic sequestration in people with sickle cell disease.there are no trials included in the review and we have not identified any relevant trials up to june 2015. |
PubMedID- 23728644 | There is a need for a well-designed, adequately-powered, randomized controlled trial to assess the benefits and risks of splenectomy compared to transfusion programmes, as a means of improving survival and decreasing mortality from acute splenic sequestration in people with sickle cell disease. |
Page: 1